umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Asthma Control and Asthma Medication Use among Swedish Elite Endurance Athletes
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.ORCID iD: 0000-0002-1684-1301
2018 (English)In: Canadian Respiratory Journal, ISSN 1198-2241, article id 4646852Article in journal (Refereed) Published
Abstract [en]

Background. Asthma is common in elite athletes. In this study, we examined the use of asthma medication and asthma control in endurance athletes in Sweden and compared the findings with those in a reference group of patients with asthma. Methods. The Asthma Control Test (ACT) and a questionnaire on asthma, respiratory symptoms, and medication use were posted to endurance athletes (n = 711) and the reference group of patients with asthma (n = 1026). Four hundred and sixty-nine athletes (66%) responded, of whom 141 (20%) reported physician-diagnosed asthma. In the reference group, 397 (39%) responded. Results. Seventy-seven percent of the athletes with asthma reported using asthma medication during the previous year; 39% used short/long-acting β2-agonists, 31% used inhaled corticosteroids, and 31% used both daily. According to the ACT scores, 19%, 24%, and 58% of athletes with asthma had uncontrolled, partially controlled, or well-controlled asthma, respectively. After adjustment, there was no difference in ACT scores or daily use of asthma medication between the study groups. Conclusions. Many endurance athletes had uncontrolled or partially controlled asthma, and one-third used inhaled corticosteroids and long-acting β2-agonists daily. Their adjusted ACT scores and use of asthma medication were similar to the values in the reference population.

Place, publisher, year, edition, pages
Hindawi Publishing Corporation, 2018. article id 4646852
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:umu:diva-147373DOI: 10.1155/2018/4646852ISI: 000429429500001OAI: oai:DiVA.org:umu-147373DiVA, id: diva2:1203357
Available from: 2018-05-03 Created: 2018-05-03 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

fulltext(1667 kB)9 downloads
File information
File name FULLTEXT01.pdfFile size 1667 kBChecksum SHA-512
c4669f428ce88fc7d5738eecdcbf196ad20e7c5fa618b23e125173cb8b2f6b4df20e1f3aa51bb4b75a89e86bd427b22abbbfcd1bd26a5d8c9518f31931563faf
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Lindberg, AnneStenfors, Nikolai

Search in DiVA

By author/editor
Lindberg, AnneStenfors, Nikolai
By organisation
Medicine
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar
Total: 9 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 86 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf